Showing all 2 results
Methoxsalen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Dissolution Tablet or Liquid-Filled Softgel, packed exclusively in highly secure, light-blocking Alu-PVC or Amber Blister strips to ensure the absolute chemical stability of the highly photoactive molecule.
Active Ingredient Strength Primary Clinical Function Methoxsalen (8-Methoxypsoralen) USP/Ph.Eur. 10 mg Global Phototherapy Standard: Weight-based dosing unit designed for exact pharmacokinetic synchronization with scheduled clinical UVA light exposure. Excipients Microcrystalline Cellulose / Pregelatinized Starch / Colloidal Silicon Dioxide / Magnesium Stearate (If Tablet) OR Macrogol (PEG 400) / Gelatin (If Softgel) Fast-Dissolving Carrier / Disintegrant / Glidant (Engineered specifically to guarantee complete gastric breakdown and maximum systemic absorption within 60 to 90 minutes, ensuring the patient is perfectly “primed” for the light booth) *Pack Sizes: Bottles of 30 or 10×10 Blisters (Optimized specifically for strict, monitored bi-weekly dermatological dispensing regimens).
Moxifloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Moxifloxacin (as Hydrochloride) Ph.Eur./USP 400 mg Global Pulmonology Standard: High-dose adult therapy for the aggressive eradication of resistant respiratory, skin, and intra-abdominal pathogens. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the highly hygroscopic API and completely mask its intensely bitter taste) *Pack Sizes: 1×5 or 10×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-14 day acute critical-care dispensing regimens).
